IPO Boutique

Mainz Biomed B.V. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Mainz Biomed B.V., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Mainz Biomed B.V.MYNZ -
NASDAQ
$4.00-$6.00 $5.00 $14.352 million11/4/2021
Boustead Securities, LLC
Co-Manager(s):
Health Care
Filing(s):

Terms Added 2021-10-28



Mainz Biomed B.V. Quote & Chart - Click for current quote - MYNZ

About Mainz Biomed B.V. (adapted from Mainz Biomed B.V. prospectus):
They are a molecular genetics cancer diagnostic company formed in 2021 to acquire PharmGenomics GmbH (“PharmGenomics“) with the purpose of commercializing their product portfolio in Europe and the United States.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "MYNZ" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved